Detalhe da pesquisa
1.
Quality-of-life effects of prostate-specific antigen screening.
N Engl J Med
; 367(7): 595-605, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22894572
2.
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.
Cancer
; 118(23): 5955-63, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22605665
3.
The impact of PLCO control arm contamination on perceived PSA screening efficacy.
Cancer Causes Control
; 23(6): 827-35, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22488488
4.
How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening.
Med Decis Making
; 31(4): 550-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21406620
5.
What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models.
Cancer Epidemiol Biomarkers Prev
; 20(5): 740-50, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21546365
6.
Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.
J Natl Cancer Inst
; 102(5): 352-5, 2010 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20142584